Navigation Links


Peer-Reviewed Study Published on Active Noise Control Device in Simulated NICU

7/18/2020
SAN ANTONIO (PRWEB) July 16, 2020 A study has been published in the journal PLOS ONE that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal intensive care unit (NICU) environment. The study reported... [Comments]

Pharmaceutical Commercial Launch Readiness, Secrets to De-Risk and Accelerate Success, Upcoming Webinar Hosted by Xtalks

7/18/2020
TORONTO (PRWEB) July 17, 2020 Commercial launch readiness is a critical stage in a product life cycle. While the world hangs on pharma’s ability to discover a COVID cure or vaccine, the global economic downturn will only increase price pressures overall for the industry. The era of increasing... [Comments]

FDAnews Announces — Overcoming Comparability Issues in Regenerative Medicines Manufacturing: The Latest on Cell and Gene Therapy Regulation Webinar, July 22, 2020

7/10/2020
FALLS CHURCH, Va. (PRWEB) July 08, 2020 Overcoming Comparability Issues in Regenerative Medicines Manufacturing: The Latest on Cell and Gene Therapy Regulation An FDAnews Webinar Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT https://www.fdanews.com/cellandgenetherapy A prod... [Comments]

CJ BIO Convenes Panel of Experts to Host Live Webinar, The Umami Advantage, During Virtual Annual Meeting of Food Scientists and Technologists

7/10/2020
CHICAGO (PRWEB) July 09, 2020 Today CJ BIO announced the first in a series of Food Ingredient MasterClass webinars, The Umami Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of... [Comments]

Aesthetics Biomedical Awarded Several Top Honors

7/4/2020
PHOENIX (PRWEB) July 03, 2020 Aesthetics Biomedical (ABM), a leading aesthetics product development corporation, is proud to earn outstanding recognition and multiple awards for not only the products and treatments developed, but also the dedicated team behind the brands under the ABM portfol... [Comments]

AltruBio Inc. moves forward with clinical development of Neihulizumab in Steroid-Refractory Acute Graft-versus-Host Disease after encouraging Phase 1a results.

7/2/2020
REDWOOD CITY, Calif. (PRWEB) July 01, 2020 AltruBio Inc. http://www.altrubio.com , a clinical stage biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology Associat... [Comments]

Ultrafast RT-PCR for COVID-19 by Molecular Biology Systems draws Dutch government support

7/2/2020
FREDERICK, Md. (PRWEB) July 02, 2020 Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 with a one-step reverse transcription polymerase chain reaction (R... [Comments]

Catalent Completes Purchase of Pharmaceutical Packaging Facility in Shiga, Japan

7/1/2020
SOMERSET, N.J. (PRWEB) July 01, 2020 Catalent, a global leader in clinical supply services, today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan. Operating in partnership with the compan... [Comments]

Silicon Beach-Based Nonprofit Startup Cure Glioblastoma Launches Laboratory Operations and Appoints Drs. John Boockvar and Lisa Haile as Senior Fellows

7/1/2020
VENICE, Calif. (PRWEB) July 01, 2020 Cure Glioblastoma, a registered 501(c)(3) nonprofit research organization focused on building awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John Booc... [Comments]

Genedata Aids Merus in Development of Precision Immunotherapies

6/28/2020
BASEL, Switzerland (PRWEB) June 25, 2020 Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that it has entered into a multi-year contract with Merus N.V., a clinical-stage oncology company developing innovative, full-length multispe... [Comments]

[previous] [next]
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered ... common and aggressive adult brain cancer—announced today the appointments of its first Senior ... with supporting the organization’s initiatives and overall vision. , "Senior Fellows are more ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions ... data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... hospitalized patients with severe COVID-19. This is the first study of an XPO1 ...
(Date:6/23/2020)... ... 2020 , ... The field of quantitation of large molecules or proteins has ... area. However, the use of mass spectrometry in this field has gained a lot ... do you choose which approach to use (LBA or MS)?” In many cases, ...
Breaking Biology News(10 mins):
...
Rubeola (Measles) Antigen Preservative: No Preservatives...
One-step, microplate or cuvet, colorimetric, linear detection range 8 mg/dL to 300 mg/dL. Procedure: 5 min....
Homo sapiens jumping translocation breakpoint...
Biology Products:
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed ... Manager Regulatory Solutions, in a one hour live webinar on Thursday, August ... in China for drugs and medical devices. Specifically, for medical devices, the NMPA has ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
Breaking Biology Technology: